Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDK1 | P06493 | 1/20 | 0.67 |
| ▸ | MEN1 | O00255 | 5/20 | 0.61 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.61 |
| ▸ | LMNA | P02545 | 4/20 | 0.61 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.61 |
| ▸ | HTT | P42858 | 2/20 | 0.61 |
| ▸ | MAPT | P10636 | 2/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.61 |
| ▸ | GAA | P10253 | 1/20 | 0.61 |
| ▸ | KIF11 | P52732 | 1/20 | 0.50 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.49 |
| ▸ | MYC | P01106 | 1/20 | 0.46 |
| ▸ | MAX | P61244 | 1/20 | 0.46 |
| ▸ | HPGD | P15428 | 1/20 | 0.43 |
| ▸ | MTOR | P42345 | 1/20 | 0.43 |
| ▸ | CXCR4 | P61073 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9453957 | 0.82 | CDK1 (0.68) | CDK1MEN1KMT2ALMNASMN1; SMN2 | |
| SCHEMBL25841058 | 0.81 | LMNA (0.72) | CDK1MEN1KMT2ALMNASMN1; SMN2 | |
| SCHEMBL14386106 | 0.81 | LMNA (0.72) | CDK1MEN1KMT2ALMNASMN1; SMN2 | |
| SCHEMBL25841306 | 0.80 | EPHX2 (0.49) | CDK1MEN1KMT2ALMNASMN1; SMN2 | |
| SCHEMBL25841012 | 0.80 | EPHX2 (0.68) | MEN1KMT2AHTTMAPTKIF11 | |
| SCHEMBL14386216 | 0.80 | CDK1 (1.00) | CDK1MEN1KMT2ALMNASMN1; SMN2 | |
| SCHEMBL25841137 | 0.79 | CDK1 (0.65) | CDK1MEN1KMT2ALMNASMN1; SMN2 | |
| SCHEMBL23328373 | 0.78 | ABAT (0.66) | CDK1MEN1KMT2ALMNASMN1; SMN2 | |
| SCHEMBL23328363 | 0.78 | CDK1 (0.63) | CDK1MEN1KMT2ALMNASMN1; SMN2 | |
| SCHEMBL31276967 | 0.78 | CDK1 (0.82) | CDK1MEN1KMT2ALMNASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11701333-B2 | Antibacterial compounds | Kent Innovation & Enterprise (GB) | 2023-07-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11701333-B2 | Antibacterial compounds | ARF1, ARL1, TLR1 | CDK1 1597/4885MEN1 1300/4885KMT2A 2533/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.